European committee takes a second look at Alzheimer’s drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
medtechdive3h
FDA breakthrough device decisions rebound after recent declines
The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...
From AI to Musk’s brain chips, the FDA’s device unit faces rapid change
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
Musk's backing of Trump in Prez poll likely to enrich his companies
Musk contributed at least $119 million to a pro-Trump spending group, federal records show, and tirelessly touted the former ...
How could Elon Musk’s clout with Donald Trump enrich his companies?
Musk has business interests that depend heavily on government regulation, subsidies or policy, from Tesla’s electric cars to ...
Musk’s brain chips to AI, how tech is challenging healthcare regulators
Christina JewettThere are now artificial intelligence programs that scan MRIs for signs of cancer, Apple AirPods that work as ...
Yahoo News15d
Why did Lakewood board approve new homes project it dubbed "detrimental"?
The suit claims that the Lakewood Planning Board improperly approved an 18-unit development it had previously ... Board Chair Moshe Neiman did not respond to requests for comment, while board attorney ...
Becker's Hospital Review17d
FDA approves expiry extension for Baxter IV products: 5 updates
Baxter has received FDA approval to extend the shelf life of more than 50 intravenous and irrigation products by up to 12 months, now allowing for a 24-month expiry from products made before ...